Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

DXCM Relative to the S&P 500

DXCM Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the DexCom Inc. (NASD:DXCM) seasonal charts above shows that a Buy Date of November 14 and a Sell Date of February 12 has resulted in a geometric average return of 8% above the benchmark rate of the S&P 500 Total Return Index over the past 19 years. This seasonal timeframe has shown positive results compared to the benchmark in 16 of those periods. This is a very good rate of success and the return outperforms the relative buy-and-hold performance of the stock over the past 19 years by an average of 1.97% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

To download DXCM seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: DXCM